USRM (US Stem Cell) Inventory Turnover: 5.00 (As of Dec. 2022)


USRM US Stem Cell Inc USRM
12 GF Score
Price $0.00
View Full Analysis

What is US Stem Cell Inventory Turnover?

US Stem Cell USRM -99.00% 12 Inventory Turnover is 5.00 as of Dec. 2022. GuruFocus rates USRM with a GF Score™ of 12/100.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. US Stem Cell's Cost of Goods Sold for the three months ended in Dec. 2022 was $0.01 Mil. US Stem Cell's Average Total Inventories for the quarter that ended in Dec. 2022 was $0.00 Mil. US Stem Cell's Inventory Turnover for the quarter that ended in Dec. 2022 was 5.00.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. US Stem Cell's Days Inventory for the three months ended in Dec. 2022 was 18.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. US Stem Cell's Inventory-to-Revenue for the quarter that ended in Dec. 2022 was 0.05.

US Stem Cell  (OTCPK:USRM) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

US Stem Cell's Days Inventory for the three months ended in Dec. 2022 is calculated as:

Days Inventory =Average Total Inventories (Q: Dec. 2022 )/Cost of Goods Sold (Q: Dec. 2022 )*Days in Period
=0.001/0.005*365 / 4
=18.25

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

US Stem Cell's Inventory to Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=0.001 / 0.02
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

US Stem Cell Inventory Turnover Related Terms

US Stem Cell Inventory Turnover Historical Data

* Premium members only.

The historical data trend for US Stem Cell's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Stem Cell Inventory Turnover Chart

US Stem Cell Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.90 26.44 9.85 10.40 24.00

US Stem Cell Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.50 7.00 7.00 5.00 5.00
USRM
12GF Score
US Stem Cell Inc USRM
Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

US Stem Cell Inventory Turnover Calculation

US Stem Cell's Inventory Turnover for the fiscal year that ended in Dec. 2022 is calculated as

Inventory Turnover (A: Dec. 2022 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2022 ) / ((Total Inventories (A: Dec. 2021 ) + Total Inventories (A: Dec. 2022 )) / count )
=0.024 / ((0 + 0.001) / 1 )
=0.024 / 0.001
=24.00

US Stem Cell's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover (Q: Dec. 2022 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Dec. 2022 ) / ((Total Inventories (Q: Sep. 2022 ) + Total Inventories (Q: Dec. 2022 )) / count )
=0.005 / ((0.001 + 0.001) / 2 )
=0.005 / 0.001
=5.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 5.00 mean?
US Stem Cell (USRM) has a Inventory Turnover of 5.00 as of Dec. 2022. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on US Stem Cell and its competitors.
Is US Stem Cell's Inventory Turnover too high?
US Stem Cell's current Inventory Turnover is 5.00. Overall, US Stem Cell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does US Stem Cell's Inventory Turnover compare to NOVNQ and RGRX?
US Stem Cell's Inventory Turnover of 5.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Biotechnology company?
A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on US Stem Cell and its competitors. US Stem Cell's current Inventory Turnover is 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Stem Cell stock overvalued right now?
US Stem Cell (USRM) has a current Inventory Turnover of 5.00. The current Inventory Turnover is 5.00. US Stem Cell's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For US Stem Cell (USRM), the current Inventory Turnover is 5.00 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

US Stem Cell Business Description

Address 1560 Sawgrass Corporate Parkway, 4th Floor, Sunrise, FL, USA, 33323
US Stem Cell Inc is a biotechnology company engaged in the discovery and development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.
12GF Score

Get the complete analysis for USRM

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price